F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comAmrutanjan Health Care Ltd is a well-established name in India’s healthcare and wellness industry. Known for its range of pain relief balms, healthcare products, and personal hygiene solutions, the company has maintained a strong presence in the Indian market for over a century. In this article, we’ll explore Amrutanjan Health Care’s share price targets from 2025 to 2030, along with its financial performance, business overview, and long-term investment potential.
| Detail | Value |
|---|---|
| Open | ₹704.90 |
| Previous Close | ₹707.35 |
| Day’s High | ₹710.00 |
| Day’s Low | ₹697.10 |
| Volume | 14,236 |
| Value (Lacs) | ₹99.89 |
| VWAP | ₹703.97 |
| Market Cap (Rs. Cr.) | ₹2,028 |
| Beta (Volatility) | 0.80 |
| 52-Week High | ₹842.90 |
| 52-Week Low | ₹544.10 |
| UC Limit | ₹848.80 |
| LC Limit | ₹565.90 |
| Face Value | ₹1 |
| Book Value Per Share | ₹103.00 |
| Dividend Yield | 0.66% |
| 20D Avg Volume | 15,720 |
| 20D Avg Delivery (%) | 52.49% |
Founded in 1893, Amrutanjan Health Care Ltd is a trusted Indian healthcare company best known for its iconic pain balm, cold rubs, and wellness products. Over the years, the company has diversified into pain management, feminine hygiene, and personal wellness segments, expanding its product portfolio with modern innovations.
Amrutanjan has also ventured into the OTC (Over-the-Counter) and digital health segments, which have helped the company adapt to changing consumer preferences. Its brand legacy and consistent focus on natural formulations give it a competitive edge in the healthcare industry.
Over 130 years of brand trust and customer loyalty
Strong distribution network across India and select international markets
Focused on innovation, R&D, and wellness product diversification
Debt-free balance sheet and consistent dividend payout history
Growing presence in the feminine hygiene and digital wellness category
| Investor Type | Holding (%) |
|---|---|
| Promoters | 46.52% |
| Retail & Others | 38.37% |
| Mutual Funds | 7.55% |
| Other Domestic Institutions | 5.15% |
| Foreign Institutions | 2.41% |
A promoter holding of over 46% ensures strong management control, while the growing presence of mutual funds and domestic institutions shows increasing confidence in the company’s fundamentals.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 720 | 760 |
| 2026 | 780 | 850 |
| 2027 | 860 | 940 |
| 2028 | 950 | 1,050 |
| 2029 | 1,080 | 1,160 |
| 2030 | 1,180 | 1,300 |
These projections are based on Amrutanjan’s financial performance, product diversification, steady earnings growth, and the expanding healthcare market in India.
By 2025, Amrutanjan Health Care is expected to maintain steady growth supported by increased demand for OTC healthcare products and seasonal wellness items.
Why?
Strong brand recall in pain relief and wellness categories
Consistent sales growth during festive and winter seasons
Low beta (0.80) indicating price stability
Investment Advice: Investors can consider accumulating the stock at current levels for medium-term gains.
In 2026, the company is likely to expand its product portfolio and distribution network.
Why?
Launch of new health and wellness products
Improved rural market penetration
Continued investment in advertising and brand building
Investment Advice: Hold the stock for long-term compounding; the company’s strong fundamentals support steady growth.
Amrutanjan may see a surge in market capitalization by 2027, driven by higher profitability and strong market share.
Why?
Growth in the feminine hygiene and digital wellness segment
Improved operational margins and cost efficiency
Brand collaborations and exports to new markets
Investment Advice: A good time to add more shares during any correction phase for long-term holding.
By 2028, Amrutanjan Health Care could cross the ₹1,000 mark, reflecting consistent revenue and EPS growth.
Why?
Expansion of e-commerce and digital sales channels
High-margin product innovations
Stable balance sheet and strong promoter management
Investment Advice: Suitable for conservative investors seeking stable returns and dividend income.
With a steady CAGR and increasing brand trust, the stock could perform strongly in 2029.
Why?
Diversification into wellness and lifestyle products
Rising healthcare spending among Indian consumers
Continuous R&D and natural product innovation
Investment Advice: Long-term investors should continue holding; the company has potential to outperform the broader FMCG index.
By 2030, Amrutanjan Health Care Ltd could solidify its position among India’s top mid-cap healthcare companies.
Why?
Expanding export markets and new product launches
Increased revenue contribution from premium wellness products
Strong cash flow and dividend-paying record
Investment Advice: Excellent long-term investment for investors seeking stable compounding and sectoral exposure to healthcare and wellness.
Yes. Amrutanjan Health Care Ltd is a fundamentally strong, debt-free company with a legacy of over a century in the wellness market. Its ability to adapt to new consumer needs while retaining brand trust makes it an attractive long-term investment.
Consistent revenue growth with healthy profit margins
Expanding wellness and hygiene product portfolio
Low debt and strong cash reserves
Regular dividend payouts
Dependence on domestic demand and seasonal sales
Competition from other FMCG and healthcare brands
Rising input and marketing costs could impact margins
Amrutanjan Health Care Ltd has shown consistent financial and operational strength over the years. With a strong brand reputation, innovation-driven growth, and expansion into digital wellness and hygiene products, the company is well-positioned for long-term success.
Currently trading around ₹704–₹710, Amrutanjan could potentially reach ₹1,300 by 2030, offering a stable and sustainable growth opportunity for long-term investors.
Investors should monitor quarterly performance, product launches, and sector trends to make informed investment decisions.
1. What is the current share price of Amrutanjan Health Care Ltd?
As of October 2025, the current price is around ₹704.90.
2. What is the share price target of Amrutanjan for 2025?
The expected target for 2025 ranges between ₹720 and ₹760.
3. What is the long-term target for Amrutanjan till 2030?
By 2030, Amrutanjan’s share price could reach between ₹1,180 and ₹1,300.
4. Who are the major shareholders of Amrutanjan Health Care Ltd?
Promoters hold 46.52%, retail investors 38.37%, and mutual funds 7.55%.
5. Is Amrutanjan Health Care a good long-term investment?
Yes, due to its stable growth, brand legacy, and consistent dividend payouts.
6. What is the dividend yield of Amrutanjan Health Care?
The company offers a dividend yield of approximately 0.66%.
7. What are the risks of investing in Amrutanjan?
Competition in the healthcare and FMCG space, along with seasonal demand variations, are potential risks.
8. What is the 52-week high and low of Amrutanjan Health Care?
The 52-week high is ₹842.90 and the 52-week low is ₹544.10.
9. What is the book value per share of Amrutanjan Health Care?
The book value per share is ₹103.00.
10. Is Amrutanjan a debt-free company?
Yes, Amrutanjan Health Care Ltd maintains a debt-free balance sheet with strong financial stability.
Disclaimer: This article is for educational purposes only. Investors are advised to conduct their own research or consult a certified financial advisor before making any investment decisions.
Register & Login